Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT01503229 · COMPLETED

Trial details

NCT number: NCT01503229
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Adenocarcinoma

Start date: 2012-12-01
Primary completion: 2020-03-12
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.